Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KUEHNE + NAGEL INTERNATIONAL AG

(KNIN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Kuehne + Nagel International : +Nagel opens new QuickSTAT pharma & healthcare control tower in Singapore

07/21/2021 | 10:08pm EDT
Singapore, SG,
22
July
2021
|
04:00
Europe/Berlin
Kuehne+Nagel Group
Kuehne+Nagel opens new QuickSTAT pharma & healthcare control tower in Singapore
  • New facility for time-critical clinical trial logistics
  • Adds value to pharma and healthcare customers in Asia Pacific

QuickSTAT, a subsidiary of Kuehne+Nagel, has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT's pharma and healthcare strategy to further expand their logistics capabilities to serve customers across Asia Pacific. As a leading biomedical science hub in the heart of Asia and its proximity to the rest of the region, Singapore is a strategic location for the new QuickSTAT facility.

QuickSTAT is an expert in managing global clinical trial logistics for all phases of the product lifecycle from research and drug development through to commercialisation. The company specialises in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies and vaccines in order to help bring new drugs and medical protocols to market safely and quickly.

QuickSTAT_2

The new conditioning facility located at Kuehne+Nagel's regional centre of excellence - the Singapore Logistics Hub - caters to a full suite of healthcare logistics services for all stages of the pharmaceutical product lifecycle. It provides superior management of cell and gene therapies, where QuickSTAT's specialists will ensure proper handling, packaging and storage of the time-and-temperature sensitive products. Additionally, the facility includes a controlled-ambient warehouse and in-transit storage for vaccines, investigational drugs, patient clinical specimens and active pharmaceutical ingredient (API).

Jack Liu, Senior Vice President, Air Logistics of Kuehne+Nagel Asia Pacific said: 'Kuehne+Nagel is delighted to partner with QuickSTAT to provide seamless end-to-end solutions, adding value to our pharma and healthcare customers in Asia Pacific. With the ISO-certified and GXP compliant facility that upholds the best practices for storage, conditioning, transportation, routings and logistics - I am confident that we will consistently deliver product integrity and patient safety.'

'We are committed to providing innovative and customised logistics as well as transportation solutions to meet the ever-challenging demands of the pharma, biotech and life science industry, in all regions of the world. By continuing to expand our global footprint to locations of strategic importance, we are able to provide local and global support for Kuehne+Nagel and QuickSTAT customers,' said Cyril Leger, Executive Vice President of QuickSTAT.

About Kuehne+Nagel

With 74,000 employees at 1,400 locations in over 100 countries, the Kuehne+Nagel Group is one of the world's leading logistics companies. Its strong market position lies in Sea Logistics, Air Logistics, Road Logistics and Contract Logistics, with a clear focus on integrated logistics solutions.

Disclaimer

Kuehne + Nagel International AG published this content on 22 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 July 2021 02:07:07 UTC.


© Publicnow 2021
All news about KUEHNE + NAGEL INTERNATIONAL AG
10/21Kuehne + Nagel International AG Reports Earnings Results for the Third Quarter and Nine..
CI
10/20GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
10/20KUEHNE + NAGEL INTERNATIONAL : + Nagel's Q3 Earnings More Than Double Amid Strong Sea, Air..
MT
10/20KUEHNE + NAGEL INTERNATIONAL : Excellent business performance continues in Q3 2021
PU
10/20Kuehne + Nagel International AG Reports Earnings Results for the Third Quarter and Nine..
CI
10/19KUEHNE + NAGEL INTERNATIONAL : Kühne+Nagel und Lufthansa Cargo vereinbaren exklusive Partn..
PU
10/14KUEHNE + NAGEL INTERNATIONAL : +Nagel Vietnam recognised as one of the Best Companies to W..
PU
10/14KUEHNE + NAGEL INTERNATIONAL : Kühne + Nagel Opens IT Competence Center in Portugal
MT
10/14PORTUGUESE HIGH TECH FOR THE WORLD : Kuehne+Nagel opens IT Hub in Porto
PU
10/04KUEHNE + NAGEL INTERNATIONAL : Kühne + Nagel Joins Lufthansa Cargo to Back Synthetic Fuel
MT
More news
Analyst Recommendations on KUEHNE + NAGEL INTERNATIONAL AG
More recommendations
Financials
Sales 2021 29 824 M 32 544 M 32 544 M
Net income 2021 1 686 M 1 840 M 1 840 M
Net cash 2021 248 M 270 M 270 M
P/E ratio 2021 21,2x
Yield 2021 2,31%
Capitalization 35 608 M 38 842 M 38 855 M
EV / Sales 2021 1,19x
EV / Sales 2022 1,18x
Nbr of Employees 71 338
Free-Float 41,8%
Chart KUEHNE + NAGEL INTERNATIONAL AG
Duration : Period :
Kuehne + Nagel International AG Technical Analysis Chart | KNIN | CH0025238863 | MarketScreener
Technical analysis trends KUEHNE + NAGEL INTERNATIONAL AG
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 295,90 CHF
Average target price 296,09 CHF
Spread / Average Target 0,06%
EPS Revisions
Managers and Directors
Detlef A. Trefzger Chief Executive Officer
Markus Blanka-Graff Chief Financial Officer
Jörg W. Wolle Chairman
Martin Kolbe Chief Information Officer
Karl Gernandt Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
KUEHNE + NAGEL INTERNATIONAL AG47.36%38 842
DSV PANALPINA A/S51.96%57 370
YUNDA HOLDING CO., LTD.23.50%8 816
INPOST S.A.0.00%7 908
NIPPON EXPRESS CO., LTD.7.07%5 904
HYUNDAI GLOVIS CO., LTD.-6.25%5 491